Analyst Research

Report Title Price
Thomson Reuters Stock Report - HUBEI QIANJIANG PHARMACEUTICAL, LTD. (600568-SH)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Zhong Zhu Holding Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Wright Investors Service Comprehensive Report for Hubei Qianjiang Pharmaceutical, Ltd.
Provider: Wright Reports
$472.00
Buy
Thomson Reuters Stock Report - HUBEI QIANJIANG PHARMACEUTICAL, LTD. (600568-SH)
Provider: Thomson Reuters Stock Report
$25.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Zhong Zhu Holding Co Ltd to Acquire Equity Shares


Friday, 28 Dec 2012 07:00pm EST 

Zhong Zhu Holding Co Ltd announced that it will acquire a 100% stake in a Zhuhai-based trade company from He Han and Guo Chengjia, at RMB 7 million. The target company is engaged in the development of real estate. 

Latest Developments for Zhong Zhu Holding Co Ltd

Latest Key Developments in Real

Company Quote

Zhong Zhu Holding Co Ltd
(600568.SS)
10.86
0.12 +1.12%
24 May 2013